FDA rejects Peninsula biotech's cancer drug — at least for now
The company, working with its partner in China, plans to ask the FDA in August to approve the drug against a type of head-and-neck cancer.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Ron Leuty Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | China Health | Head and Neck Cancer | Health Management